[Effect of DOPA and alpha-methyl-DOPA on the development of neurogenic dystrophy of the gastric wall and catecholamine content of the stomach].
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004558:Electric Stimulation; D004837:Epinephrine / Q000378:metabolism*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000378:metabolism
D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine; D004837:Epinephrine
Vliianie DOFA i al'fa-metil-DOFA na razvitie neĭrogennoĭ distrofii stenki zhelukda i uroven' v neĭ katekholaminov.